Stock Events

Stock Events

Nova Eye Medical Limited 

A$0.135000
6
+A$0.00+0% 01:18 Today

Statistics

Day High
0.135
Day Low
0.13
52W High
0.205
52W Low
0.1
Volume
40,730
Avg. Volume
261,466
Mkt Cap
38.46M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 20
A$0.29
Jul 20
A$0.14
Dec 2
A$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26AugExpected
Q3 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0.03
-0.02
-0.01
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-30.95%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
29.27MRevenue
-9.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EYE.AU. It's not an investment recommendation.
Fortescue
2
FMG.AU
Australian Foundation Invest.
2
AFI.AU
Whitefield Industrials
2
WHF.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, competes in various healthcare sectors including eye health, making it a competitor in the ophthalmic market.
Novartis
NVS
Mkt Cap292.35B
Novartis AG, with its division Alcon, specializes in eye care products ranging from surgical devices to contact lenses, directly competing in Nova Eye Medical's market.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, after acquiring Allergan, has a strong presence in the eye care market, especially in treatments for eye conditions, competing with Nova Eye Medical's offerings.
Bausch Health Companies
BHC
Mkt Cap2.36B
Bausch Health Companies, through its subsidiary Bausch + Lomb, provides a wide range of eye health products, competing across several of Nova Eye Medical's key areas.
Cooper Companies
COO
Mkt Cap13.88B
The Cooper Companies operate through CooperVision and CooperSurgical, with CooperVision being a significant player in the contact lens market, indirectly competing with Nova Eye Medical.
Staar Surgical
STAA
Mkt Cap1.11B
STAAR Surgical Company specializes in the development, manufacture, and marketing of implantable lenses for the eye and delivery systems, competing in the surgical eye care segment.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences, a provider of surgical instruments and devices, competes in the broader medical technology market, including some ophthalmic surgical products.

About

Headquartered in Kent Town, Australia, and established in 1985, Nova Eye Medical Limited is dedicated to the development, manufacturing, and global commercialization of surgical solutions for eye conditions, with a primary focus on glaucoma. Their product lineup features the iTrack surgical system, engineered to reduce intraocular pressure in adult patients with open-angle glaucoma, alongside its evolution, iTrack Advance, which promotes natural ocular fluid drainage. For individuals with severe or intricate forms of glaucoma, they provide the Molteno3 drainage device. Additionally, the company offers 2RT, a unique laser technology aimed at treating early to intermediate age-related macular degeneration. Nova Eye Medical Limited maintains a significant international footprint, conducting operations across Australia, the United States, Europe, and the Asia Pacific region. The company officially adopted its current name in July 2020, having previously operated as Ellex Medical Lasers Limited.
Show more...
CEO
Tom Spurling
Employees
301
Country
Australia
ISIN
AU0000094252

Listings

OTC Link
US
ELXMF
AU
AU
EYE.AU

0 Comments

Share your thoughts

FAQ

What is Nova Eye Medical Limited stock price today?▼
The current price of EYE.AU is A$0.14 AUD — it has increased by +0% in the past 24 hours. Watch Nova Eye Medical Limited stock price performance more closely on the chart.
What is Nova Eye Medical Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Nova Eye Medical Limited stocks are traded under the ticker EYE.AU.
Is Nova Eye Medical Limited stock price growing?▼
EYE.AU stock has risen by +0% compared to the previous week, the month change is a -3.57% fall, over the last year Nova Eye Medical Limited has showed a -3.57% decrease.
What is Nova Eye Medical Limited market cap?▼
Today Nova Eye Medical Limited has the market capitalization of 38.46M
When is the next Nova Eye Medical Limited earnings date?▼
Nova Eye Medical Limited is going to release the next earnings report on March 02, 2027.
What is Nova Eye Medical Limited revenue for the last year?▼
Nova Eye Medical Limited revenue for the last year amounts to 29.27M AUD.
What is Nova Eye Medical Limited net income for the last year?▼
EYE.AU net income for the last year is -9.06M AUD.
Does Nova Eye Medical Limited pay dividends?▼
Yes, EYE.AU dividends are paid en. The last dividend per share was 0.29 AUD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Nova Eye Medical Limited have?▼
As of September 04, 2026, the company has 301 employees.
In which sector is Nova Eye Medical Limited located?▼
Nova Eye Medical Limited operates in the Health & Wellness sector.
When did Nova Eye Medical Limited complete a stock split?▼
Nova Eye Medical Limited has not had any recent stock splits.
Where is Nova Eye Medical Limited headquartered?▼
Nova Eye Medical Limited is headquartered in Kent Town, Australia.